Reproductive and Genetic Technologies

Germline editing: the one change that becomes heritable

Human reproductive and genetic technology has advanced to a point where several distinct, genuinely demonstrated techniques now exist, and the exam-relevant skill is knowing exactly what each one does rather than treating them as a single blurred category of "genetic modification".

Germline gene editing modifies the gametes, the sperm and egg cells (and the embryonic cells that give rise to them), that a person actually passes on to their offspring. This is the critical distinction from every other form of gene therapy: editing a patient's own body cells (somatic gene therapy) affects only that one patient, while editing a germline cell makes the change heritable, passed down to every subsequent generation descended from that individual. This has already been attempted in humans, most notoriously in China in 2018, when a researcher used CRISPR-Cas9 to edit the genome of human embryos, an act that provoked international condemnation precisely because of that heritability, and because the edited embryos were brought to term as live births.

A related but distinct technique, human-animal chimera research, has also moved from theory to demonstration: researchers have injected human induced pluripotent stem cells into pig embryos to create human-animal chimeras for research purposes, with the long-term aim of eventually studying organ development or growing transplantable human organs inside a host animal. This is not germline editing, since it does not alter what a human passes on to offspring, but it belongs in the same cluster of ethically fraught, already-demonstrated reproductive and developmental biotechnology.

Pronuclear transfer: preventing a specific class of inherited disease, not choosing a child's traits

Pronuclear Transfer is a specific, narrowly purposed mitochondrial replacement technique, sometimes informally called a "three-parent" method, and its precise purpose is worth distinguishing sharply from other reproductive technologies it is often confused with. Mitochondria, the energy-producing organelles inside a cell, carry their own small stretch of DNA, separate from the main nuclear DNA, and mitochondrial DNA is inherited exclusively from the mother. When a mother's mitochondria carry a disease-causing defect, every child she has by conventional conception inherits that same defective mitochondrial DNA.

Pronuclear transfer addresses this directly: the nuclear DNA from a fertilised egg carrying the mother's defective mitochondria is removed and transferred into a donor egg that has had its own nucleus removed but retains healthy donor mitochondria. The resulting embryo carries the intended parents' nuclear DNA (the vast majority of the child's genetic identity) alongside a small amount of healthy mitochondrial DNA from the donor, preventing the mitochondrial disease from being passed on.

What pronuclear transfer is not used for is equally worth fixing precisely: it is not a technique for selecting a child's sex before implantation, not a method for increasing the number of viable embryos produced in a single IVF cycle, and not a way to screen embryos for chromosomal disorders such as Down syndrome. Each of those is a separate, established reproductive technology in its own right; pronuclear transfer's purpose is specifically preventing mitochondrial disease transmission, and nothing else on that list.

Quick revision points

• Germline gene editing modifies gametes (sperm/egg or their precursor cells), making a change heritable to all descendants, unlike somatic gene therapy which affects only the treated individual. Human embryos have already been edited this way (China, 2018), an act widely condemned specifically because of that heritability.
• Human-animal chimeras: human induced pluripotent stem cells injected into pig embryos, aimed at eventually studying organ development or growing transplantable organs. Distinct from germline editing since it does not alter inheritance.
• Pronuclear Transfer: a mitochondrial replacement technique (a "three-parent" method) that moves a fertilised egg's nuclear DNA into a donor egg with healthy mitochondria, preventing mitochondrial disease transmission. It is NOT used for sex selection, increasing IVF embryo yield, or screening for chromosomal disorders like Down syndrome, each a separate, established technology.